Cancer

Quality control is an integral part of the New Jersey State Cancer Registry (NJSCR). We review and evaluate the quality and completeness of our data through routine edit programs, visual review, re-abstracting studies and casefinding audits. We also strive to improve data collection activities through targeted training programs for hospital cancer registrars. The NJSCR has been routinely awarded the highest possible ratings for each of the three national surveillance programs, including the North American Association of Central Cancer Registries (NAACCR) Gold Standard from 1995 through the present (excluding 2011), the CDC National Program of Cancer Registries Registry of Excellence Award, and the NCI SEER Program 1^st Place Award, meeting 14 of 14 data quality indicators.  These awards are based on completeness of cancer case ascertainment, completeness of specific information on the cancer cases, percent of death certificate only cases, percent of duplicate cases, in addition to passing the data through a stringent edit program.

The NJSCR is a participant in the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR).  We acknowledge the Centers for Disease Control and Prevention for its support of the NJSCR under the cooperative agreement NU58DP007117 awarded to the New Jersey Department of Health.  New Jersey cancer incidence data is also included in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program research dataset. The NJSCR is also a member of NAACCR and the International Association of Cancer Registries (IACR).